Active Ingredients: clemastine fumarate, USP 1.34 mg (equivalent to 1 mg clemastine). Inactive Ingredients: lactose, povidone, starch, stearic acid, and talc.

Sodium Free.

Temporarily reduces runny nose and sneezing due to hay fever or other respiratory allergies due to the common cold. Temporarily reduces itching of the nose or throat and itchy, watery eyes due to hay fever or other upper respiratory allergies.

:   Keep this and all drugs out of the reach of children. In case of accidental overdose, seek professional assistance or contact a poison control center immediately. May cause drowsiness; alcohol, sedatives, and tranquilizers may increase the drowsiness effect. Avoid alcoholic beverages while taking this product. Do not take this product if you are taking sedatives or tranquilizers without first consulting your doctor. Use caution when driving a motor vehicle or operating machinery. May cause excitability especially in children. Do not take this product, unless directed by a doctor, if you have a breathing problem such as emphysema or chronic bronchitis, or if you have glaucoma or difficulty in urination due to enlargement of the prostate gland. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health professional before using this product.

Directions:   Adults and children 12 years of age and older: Swallow 1 tablet every 12 hours, not to exceed 2 tablets in 24 hours unless directed by a doctor. Children under 12 years of age: Consult a doctor.

How Supplied: Tavist Allergy tablets (white) imprinted Tavist on one side and Allergy on the other side in blister packs of 8, 16, and 32.

Formerly Tavist-1®

PRODUCT PHOTO(S):

NOTE: These photos can be used only for identification by shape, color, and imprint. They do not depict actual or relative size.

The product samples shown here have been supplied by the manufacturer and reproduced in full color by PDR as a quick-reference identification aid. While every effort has been made to assure accurate reproduction, please remember that any visual identification should be considered preliminary. In cases of poisoning or suspected overdosage, the drug' identity should be verified by chemical analysis.